Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123695872 | 12369587 | 2 | F | 201604 | 20160517 | 20160516 | 20160819 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022660 | GLENMARK | 0.00 | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123695872 | 12369587 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, ONE CAPSULE DAILY | Y | 91672 | 20 | MG | QD | ||||||
| 123695872 | 12369587 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 123695872 | 12369587 | 3 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 123695872 | 12369587 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 123695872 | 12369587 | 5 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 123695872 | 12369587 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, UNK | 0 | 81 | MG | TABLET | |||||||
| 123695872 | 12369587 | 7 | C | IMMUNOGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123695872 | 12369587 | 1 | Gastrooesophageal reflux disease |
| 123695872 | 12369587 | 2 | Hypothyroidism |
| 123695872 | 12369587 | 3 | Product used for unknown indication |
| 123695872 | 12369587 | 4 | Product used for unknown indication |
| 123695872 | 12369587 | 5 | Hypersensitivity |
| 123695872 | 12369587 | 6 | Product used for unknown indication |
| 123695872 | 12369587 | 7 | Myasthenia gravis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123695872 | 12369587 | Diarrhoea | |
| 123695872 | 12369587 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123695872 | 12369587 | 1 | 201604 | 20160416 | 0 |